Molecular basis for different ability of low-density and high-density lipoproteins to support activity of the intrinsic Xase complex

Author： Khrenov A.   Sarafanov A.   Ananyeva N.   Kouiavskaia D.   Shima M.   Schwinn H.   Josic D.   Saenko E.  

Publisher： Elsevier

ISSN： 0049-3848

Source： Thrombosis Research, Vol.105, Iss.1, 2002-01, pp. : 87-93

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Malondialdehyde-modified low-density lipoproteins as biomarker for atherosclerosis

By Viigimaa Margus   Abina Jelena   Zemtsovskaya Galina   Tikhaze Alla   Konovalova Galina   Kumskova Elena   Lankin Vadim  

Blood Pressure, Vol. 19, Iss. 3, 2010-06 ,pp. : 164-168

Informa Healthcare

Access to resources Recommend Favorite

The Role of High-Density Lipoproteins in Oxidation and Inflammation

By Van Lenten B.J.   Navab M.   Shih D.   Fogelman A.M.   Lusis A.J.  

Trends in Cardiovascular Medicine, Vol. 11, Iss. 3, 2001-04 ,pp. : 155-161

Elsevier

Access to resources Recommend Favorite

Molecular Requirements in the Recognition of Low-Density Lipoproteins (LDL) by Specific Platelet Membrane Receptors

By Pedreno J.   Sanchez-Quesada J.L.   Cabre A.   Masana L.  

Thrombosis Research, Vol. 99, Iss. 1, 2000-07 ,pp. : 51-60

Elsevier

Access to resources Recommend Favorite

Effect of hypochlorite (HOCl)-modified low density lipoproteins and high density lipoproteins on platelet function

By Opper C.   Schussler G.   Sattler W.   Malle E.  

Platelets, Vol. 9, Iss. 5, 1998-10 ,pp. : 339-340

Informa Healthcare

Access to resources Recommend Favorite

Diene-conjugates and antibodies against oxidized low-density lipoproteins in systemic sclerosis

By Simonini G.   Falcini F.   Generini S.   Pignone A.   Cerinic M.M.  

European Journal of Internal Medicine, Vol. 11, Iss. 5, 2000-10 ,pp. : 289-289

Elsevier

Access to resources Recommend Favorite